Category

China

Daily Brief China: Leapmotor, Bilibili, Onewo, China Datang Corp Renewable Power, CNY, Joinn Laboratories (H), CIFI Holdings and more

By | China, Daily Briefs

In today’s briefing:

  • Leapmotor IPO – Weak Demand but Concentrated Allocation
  • Bilibili (9626 HK): Implications of Dual Primary Listing
  • Onewo Space-Tech IPO Trading – Weak but Relatively Better Demand
  • Leapmotor IPO: Trading Debut
  • Onewo IPO: Trading Debut
  • Leapmotor IPO: Thoughts on First Day Trading
  • China Datang Renewable Power (1798): Ideal Name for ESG Fund.
  • Consequential Currency
  • Joinn Laboratories (6127.HK) 22H1 – It’s Time to Face Reality Before the Magic of Monkeys Disappears
  • Morning Views Asia: AAC Technologies Holdings, CIFI Holdings

Leapmotor IPO – Weak Demand but Concentrated Allocation

By Sumeet Singh

  • Leapmotor (9863 HK) raised around US$800m in its Hong Kong IPO. LM is a smart EV company based in China, founded in 2015.
  • As of end Jun 22, it had delivered a total of 104,829 cars with most of its sales coming from its mini units, T03.
  • In this note, we will talk about the demand for the deal and other trading dynamics.

Bilibili (9626 HK): Implications of Dual Primary Listing

By Brian Freitas


Onewo Space-Tech IPO Trading – Weak but Relatively Better Demand

By Sumeet Singh

  • Onewo (2602 HK) (OST) raised around US$733m in its Hong Kong IPO. OST is a property management service provider primarily owned by China Vanke Co Ltd (H) (2202 HK) . 
  • As per Frost & Sullivan, amongst the residential community service providers in China, OST ranked first. It also ranked first in the commercial space integrated services market in China.
  • In this note, we will talk about the demand for the deal and other trading dynamics.

Leapmotor IPO: Trading Debut

By Arun George

  • Leapmotor (9863 HK) priced its H Share at HK$48.00 per share to raise net proceeds of HK$6,057.4 million (US$772 million). The H Share will start trading tomorrow.
  • The H Shares of peers posted no first-day gains and are currently below the listing prices. Market sentiment on peers has remained weak since the release of the prospectus.
  • Leapmotor, at best, should trade in line with median peer multiples. Leapmotor is fairly valued at the IPO price. We continue to remain on the sidelines.

Onewo IPO: Trading Debut

By Arun George

  • Onewo (2602 HK) priced its H Share at HK$49.35 per share to raise net proceeds of HK$5.6 billion (US$713 million). The H Share will start trading tomorrow.
  • Notwithstanding the industry headwinds, the H Shares of peers with financially sound parentco backgrounds are trading above the listing prices.
  • Despite peer multiple derating, the IPO price remains attractive compared to peers with financially sound parentco backgrounds. 

Leapmotor IPO: Thoughts on First Day Trading

By Shifara Samsudeen, ACMA, CGMA

  • Leapmotor (9863 HK) has priced its IPO at HK$48 per share, at the lower end of the indicative IPO price range of HK$48-62 per share. 
  • At the above price, the company raised net proceeds of approx. HK$6,057.4m at a market capitalisation of HK$54.9bn and a post-money EV of HK$45.9bn.
  • The HK offering was undersubscribed while the international offering was initially oversubscribed by 2.33x and the unsubscribed portion of the HK offering was later reallocated to international offering.

China Datang Renewable Power (1798): Ideal Name for ESG Fund.

By Henry Soediarko

  • Low valuation against peers in China albeit China Datang Corp Renewable Power (1798 HK) is one of the few pure-play wind farm operators in HK. 
  • Its free cash flow reached its highest in more than 10 years. 
  • The challenging equity market makes China Datang Renewable Power looks even more attractive.

Consequential Currency

By Untying The Gordian Knot

  • I usually work with a base case view and not the most optimistic or pessimistic take, and this note is no different.
  • Its approach is forming an opinion on more probable in the next move and avoiding click baits 2-3 σ price targets.
  • I was expecting to do this note the following Monday as I thought with the NPC meeting and directive to state banks to act accordingly, any downward pressure on CNY would be avoided or measured.

Joinn Laboratories (6127.HK) 22H1 – It’s Time to Face Reality Before the Magic of Monkeys Disappears

By Xinyao (Criss) Wang

  • The monkeys have become Joinn Laboratories (H) (6127 HK)’s important profit growth point based on the logic chain of “monkey supply shortage – monkey price rise – Joinn’s performance increase”. 
  • Faced with doubts about the future prosperity of CXO, we don’t think Joinn is immune as a part of this industrial chain. Joinn is hard to achieve the V-shaped rebound.
  • Valuations are hard to increase by when the industry is very mature.For investment logic, my favorite is the industry beta, followed by industry beta+alpha. The last is low P/E ratio.

Morning Views Asia: AAC Technologies Holdings, CIFI Holdings

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Tencent, Jinke Smart Services, Swire Pacific (B), Vipshop Holdings, Poly Real Estate Group Co., Ltd, Medlive Technology, Road King Infrastructure and more

By | China, Daily Briefs

In today’s briefing:

  • Tencent Investee Selldown – The US$120bn Global Overhang
  • Jinke Smart (9666 HK)’s Low-Balled But Virtually Unconditional Offer
  • Swire B Vs A – Surprising on Regs, Surprising on Risk; Short-Tm Displacement Now in 99th Percentile
  • Jinke Smart’s VGO of HK$12.00 from Boyu Capital
  • Tencent Increases Its Investment in Medical and Healthcare
  • Vipshop: Rebound in Chinese Apparel Sales Should Trump Conservative Management Guidance
  • FTSE China A50 Index Rebalance Preview: Tight Margins
  • Medlive Technology (2192.HK) 22H1- The Growth Logic/Business Model Is More Scrutinized by the Market
  • Morning Views Asia: Road King Infrastructure

Tencent Investee Selldown – The US$120bn Global Overhang

By Sumeet Singh

  • Multiple new agencies have been reporting that Tencent (700 HK) plans to trim its investment portfolio over the remainder of the year. 
  • The reports have been coming in since the second half of the year and the company has been duly denying these rumors.
  • In this note, we look at Tencent’s shareholding in various companies to try and gauge which ones it could sell out of and how.

Jinke Smart (9666 HK)’s Low-Balled But Virtually Unconditional Offer

By David Blennerhassett

  • PRC-Incorporated property management play Jinke Smart Services (9666 HK) has announced a voluntary cash offer at HK$12/share, a 33.04% premium to last close.
  • The Offeror (Boyu) and concert parties collectively hold more than 50%. The Offer is contingent on regulatory approvals and 7.71% of shares out tendering. The tendering condition can be waived.
  • The Offer appears geared to bring Boyu’s stake in line with Jinke Property Group (000656 CH)‘s. 

Swire B Vs A – Surprising on Regs, Surprising on Risk; Short-Tm Displacement Now in 99th Percentile

By Travis Lundy

  • The Swire buyback has been impressive. In 27 trading days they have bought back 26.8% of teh HK$4bn promised. In that period, participation has been aggressive.
  • Swire has bought back As at a pace of 52% of pre-buyback one-year ADV. For Bs, it has been 105%. But Bs have dramatically underperformed As on “HK Re-opening” trades.
  • Historically, when B/A gets more than 6% from 3mo Avg VWAP Ratio, there is statistically significant reversion. We are now at 6.8%. I’d buy B vs A.

Jinke Smart’s VGO of HK$12.00 from Boyu Capital

By Arun George

  • Jinke Smart Services (9666 HK) announced a voluntary conditional general offer from Boyu Capital at HK$12.00 per share, a 33.0% premium to the undisturbed price.
  • The offer is conditional on 7.71% valid acceptances (such that Boyu represents 30.40% of outstanding shares) and anti-trust approval. The conditions can be waived.  
  • The offer is designed to flush out minorities unwilling to wait for the industry headwinds to dissipate. A low threshold suggests that the offer will be declared unconditional.

Tencent Increases Its Investment in Medical and Healthcare

By Shifara Samsudeen, ACMA, CGMA

  • Tencent known to outspend its peers on strategic investments, has made only around 80 investments and acquisitions so far this year compared to more than 200 deals done in 2021.
  • Tencent’s vast investment portfolio has attracted regulatory scrutiny and it’s the market’s belief that Tencent was asked to divest some of its stake in other leading tech players in China.
  • However, over the last few months, Tencent has been increasingly investing on companies operating in the medical field.

Vipshop: Rebound in Chinese Apparel Sales Should Trump Conservative Management Guidance

By Wium Malan, CFA

  • Following a contraction in Chinese apparel sales since 3Q21, and similar negative GMV and product revenue growth for Vipshop, we have witnessed a recovery to growth since June.
  • Current sell-side forecasts are, however, still for a -10.8%y/y contraction in product revenue for Vipshop in 3Q22f, followed by a -4.4% contraction in 4Q22f which seems overly pessimistic.
  • Given the conservative nature of near-term top-line growth expectation, and management guidance, the probability for positive earnings surprise seems high.

FTSE China A50 Index Rebalance Preview: Tight Margins

By Brian Freitas

  • Poly Real Estate Group Co., Ltd (600048 CH) sits at the edge of the inclusion zone for the FTSE China A50 Index (XIN9I INDEX) December rebalance.
  • That inclusion could result in the deletion of any one of four stocks since they are all clustered within 0.7% of each other on full market cap.
  • There are a few other stocks that are close to inclusion zone and a 5-10% rally in these stocks could result in more changes to the index in December.

Medlive Technology (2192.HK) 22H1- The Growth Logic/Business Model Is More Scrutinized by the Market

By Xinyao (Criss) Wang

  • The improvement of Medlive’s profitability in 22H1 seems more related to the large decreased income tax expense rather than any obvious improvement of main business or any other logic.
  • The single main business structure and insufficient core competitiveness add uncertainty to the Company’s long-term prospects, which makes it difficult to significantly improve the valuation.
  • Medlive is under double pressure of “squeezing bubble” in healthcare industry and “the fading of traffic dividend” in Internet industry.Its growth logic/business model will be more scrutinized by the market.

Morning Views Asia: Road King Infrastructure

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Pine Care Group, Shandong Fengxiang, Alibaba Group, Onewo, Growatt Technology, Times China, Xinjiang Goldwind Science & Technology H and more

By | China, Daily Briefs

In today’s briefing:

  • Pine Care Group – Another MGO, Still Wrong Price Making One Wonder…
  • Merger Arb Mondays (26 Sep) – Fengxiang, Lifestyle, EVOC, DTAC/True, VNET, 111, Ramsay, Genex
  • Alibaba: Accelerating Retail Sales, and a Depressed Comp Base, Bode Well for Near-Term Earnings
  • Onewo (2602 HK): No Passive Flow or Stock Connect Inclusion
  • Growatt Technology IPO: The Bear Case
  • China Internet Weekly (26Sep2022): S.F., STO, YTO, Yunda, JD Logistics, Alibaba, Baidu, Trip.com
  • Morning Views Asia: Tata Steel Thailand, Times China
  • Xinjiang Goldwind (2208 HK): Getting to a More Attractive Point Again

Pine Care Group – Another MGO, Still Wrong Price Making One Wonder…

By Travis Lundy

  • In early Feb2020, the #1 shareholder of HK-based elderly home care provider Pine Care Group (1989 HK) sold a 52% stake at HK$1.647, keeping 14.99%. That triggered an Unconditional MGO. 
  • In Aug2022, much of the shareholder consortium which bought in 2020 agreed to sell 56.15% at HK$0.89/share to local privately-held developer Chinachem. That will trigger another Unconditional MGO.
  • The business has suffered under covid, but it is not clear why the business would be better now. Revenues will spike when Causeway Bay opens, but…. Sell. 


Alibaba: Accelerating Retail Sales, and a Depressed Comp Base, Bode Well for Near-Term Earnings

By Wium Malan, CFA

  • In line with previously reported trends in Chinese retail sales growth, the large Chinese eCommerce operators reported a decline (or contraction) in GMV growth in 2Q2022.
  • Following a contraction between March and May this year, China’s retail sales growth has returned to growth since June, which continued in July and accelerated in August.
  • Alibaba’s next reported quarter’s annualised growth will be on an extremely depressed base.

Onewo (2602 HK): No Passive Flow or Stock Connect Inclusion

By Brian Freitas

  • Onewo (2602 HK) is looking to raise between US$700m-US$784m by selling 116.714m shares at a price range of HK$47.1-52.7/share. Indications are that the IPO will be priced close to mid-point.
  • Given the domestic shares and unlisted foreign shares will not be converted to H-shares, there is no chance of MSCI inclusion and a small chance of FTSE inclusion.
  • Onewo (2602 HK) is also unlikely to be added to the HSCI and consequently will not be added to Stock Connect.

Growatt Technology IPO: The Bear Case

By Arun George

  • Growatt Technology (1833969D CH), a leading PV inverters manufacturer, will seek a listing hearing for a US$1 billion HKEx IPO in October, according to press reports.
  • In Growatt Technology IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case. 
  • The key elements of the bear case rest on rising customer concentration risk, high dependence on Brazil for growth, limited pricing power and a shift to FCF burn. 

China Internet Weekly (26Sep2022): S.F., STO, YTO, Yunda, JD Logistics, Alibaba, Baidu, Trip.com

By Ming Lu

  • Revenues of major express parcel companies grew rapidly in August.
  • JD logistics will provide logistics service to live streaming retailers on Douyin.
  • In 2Q22, revenue of Trip.com decreased by 32% YoY and operating profit turned negative.

Morning Views Asia: Tata Steel Thailand, Times China

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Xinjiang Goldwind (2208 HK): Getting to a More Attractive Point Again

By Osbert Tang, CFA

  • Xinjiang Goldwind Science & Technology H (2208 HK) had a tough 2Q22; but with the recent retreat in share price, the stock appears attractive now at 8.5x FY23F PER.  
  • Goldwind has many growth initiatives backing its outlook. These include solid order backlog, upside on gross margin, contribution from wind farms and growth from the servicing business.
  • Its WTG backlog of 24.1GW is 1.3x higher QoQ and well covers revenue for next two years. Further strategic disposals of wind farm will help realising underlying asset values.  

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Leapmotor, CALB, Pine Care Group, Jenscare Scientific, Tianqi Lithium, Wuxi Biologics, Agile Property Holdings, Lepu Scientech Medical Technology (Shanghai) and more

By | China, Daily Briefs

In today’s briefing:

  • Leapmotor (9863 HK) IPO – Stock Connect & Index Flows Could Provide Some Support
  • CALB IPO – Low-End Appears Reasonable but Will Still Need Some Charging Support
  • Pine Care Group (1989 HK): Chinachem Takeover Offers a Good Exit Opportunity for Investors
  • Jenscare (健世科技) IPO: Candidate for Shorts
  • CALB IPO Valuation Analysis
  • Shanghai/​​​​​​​​​​​​​Shenzhen Northbound Connect: Weekly Moves (22 September 2022)
  • Shanghai/​​​​​​​​​​​​​Shenzhen Southbound Connect: Weekly Moves (23 September 2022)
  • Chinese Property Weekly – 23 September 2022 – Lucror Analytics
  • Chinese Property Weekly – 23 September 2022 – Lucror Analytics
  • Lepu Scientech Medical Technology Pre-IPO Tearsheet

Leapmotor (9863 HK) IPO – Stock Connect & Index Flows Could Provide Some Support

By Brian Freitas

  • Leapmotor (9863 HK) is looking to raise between US$800m-US$1.03bn by selling 130.82m shares at a price range of HK$48-62/share. Between 30-39% of the shares will be taken by cornerstone investors.
  • The continued slide in its closest peers could put pressure on the stock post listing, though there could be some passive buying in December.
  • Leapmotor (9863 HK) could be added to the HSCI and Hang Seng Tech Index (HSTECH INDEX) in December. Stock Connect could come online in December too.

CALB IPO – Low-End Appears Reasonable but Will Still Need Some Charging Support

By Sumeet Singh

  • CALB aims to raise up to US$1.7bn in its Hong Kong IPO.
  • CALB undertakes design, R&D, production and sales of EV batteries and Energy Storage Systems (ESS) products.
  • In this note, we will run the deal through our ECM framework and talk about IPO pricing.

Pine Care Group (1989 HK): Chinachem Takeover Offers a Good Exit Opportunity for Investors

By Tina Banerjee

  • Hong Kong’s leading property developer, Chinachem Group agreed to acquire a 56.15% stake in Pine Care Group (1989 HK) for HKD451.2 million ($57.5 million) from its controlling shareholders.
  • Post-Acquisition, Chinachem will launch an unconditional mandatory offer for the remaining shares, which it does not hold at HKD0.89 per share, same as the purchase price.
  • Considering delisting risk, limited upside potential of the shares after a huge run-up, and muted growth outlook of the company, investors should tender their holdings.  

Jenscare (健世科技) IPO: Candidate for Shorts

By Ke Yan, CFA, FRM

  • Jenscare is a China-based medical device company with a focus on structural heart disease. The company launched a deal to  raise up to USD 30m via a Hong Kong listing.
  • In our previous note, we looked at the company’s product lines and provided a brief overview on the company’s valuation.
  • In this note, we provide an update for the book building. We provide our quick thoughts on the valuation and deal dynamics.

CALB IPO Valuation Analysis

By Douglas Kim

  • CALB (3931 HK) is getting ready to complete its IPO in early October in Hong Kong. The IPO price range is between HK$38 and HK$51 per share.
  • Based on our valuation sensitivity analysis, our base case valuation of CALB is HK$53 per share, which is 20% higher than the mid-point of the IPO price range.
  • CALB has a rare combination of surging sales growth rate, operating profitability, and increasing market share in the EV battery market globally.

Shanghai/​​​​​​​​​​​​​Shenzhen Northbound Connect: Weekly Moves (22 September 2022)

By David Blennerhassett


Shanghai/​​​​​​​​​​​​​Shenzhen Southbound Connect: Weekly Moves (23 September 2022)

By David Blennerhassett

  • Inside is a recap of movements in the last week relating to the Shanghai and Shenzhen-Hong Kong Stock Connect facilities, broken down by company and industry.
  • Overall, the net inflow over the past week was ~US$1.1bn, split (+US$0.8bn) for Shanghai and (+US$0.3bn) for Shenzhen.
  • The largest inflows were into Wuxi Biologics (2269 HK) and Tencent (700 HK). The largest outflows were in Geely Auto (175 HK) and HKEX (388 HK).

Chinese Property Weekly – 23 September 2022 – Lucror Analytics

By Charles Macgregor

The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.


Chinese Property Weekly – 23 September 2022 – Lucror Analytics

By Charles Macgregor

The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.


Lepu Scientech Medical Technology Pre-IPO Tearsheet

By Ethan Aw

  • Lepu Scientech Medical Technology (Shanghai) (LSM HK) is looking to raise at least US$100m in its upcoming Hong Kong IPO. The deal will be run by CICC. 
  • Lepu Scientech Medical Technology (LSMT) is an interventional medical device provider in China for congential heart disease (CHD).
  • It is the largest manufacturer of CHD occluder products and related procedural accessories in China, according to Frost & Sullivan.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Shandong Fengxiang, Angelalign Technology, Leapmotor, SKYX Platforms, Central China Real Estate, Jupiter Wellness, CIFI Holdings, Air China Ltd (H), Bruush Oral Care and more

By | China, Daily Briefs

In today’s briefing:

  • Fengxiang (9977 HK): MGO Expected To Follow Judicial Auction
  • Angelalign Technology (6699 HK): 1H22 Profit Drops As Challenging Operating Environment Continued
  • Leapmotor IPO Valuation Analysis
  • SKYX Platforms Inc. – Investment Thesis
  • Central China – Tear Sheet – Lucror Analytics
  • Jupiter Wellness – Investment Thesis, Key Drivers, Financial & Price Forecasts, DCF Valuation 09/22
  • Angelalign Technology (6699.HK) 22H1 – Still “Bubble” in Valuation; The Era of High Margin Is Over
  • Morning Views Asia: CIFI Holdings
  • Air China (753 HK): Can It Sustain the Outperformance?
  • Bruush Oral Care – Investment Thesis, Key Drivers, Financial & Price Forecasts, DCF Valuation 07/22

Fengxiang (9977 HK): MGO Expected To Follow Judicial Auction

By David Blennerhassett

  • The controlling shareholders of Shandong Fengxiang Co Ltd-H (9977 HK),  a company engaged in chicken breeding, slaughtering, and processing, are unable to meet their debts.
  • As such, these shareholders who hold 70.92% of shares out in Fengxiang, via domestic shares, have been forced into a judicial auction, the completion of which may trigger an MGO. 
  • Taking pointers from Dongzheng Automotive Finance (2718 HK)‘s recent auction means we back out a possible payment around late December – on the assumption an unconditional MGO is triggered.

Angelalign Technology (6699 HK): 1H22 Profit Drops As Challenging Operating Environment Continued

By Tina Banerjee

  • Angelalign Technology (6699 HK) has reported muted H1 2022 results, which were negatively impacted by the resurgence of the COVID-19 pandemic in China and the corresponding restrictions.
  • Revenue from core business of clear aligner treatment grew just 3% y/y. However, lower ASP and higher cost of sales, pulled down the gross profit margin by 930bps to 60.2%.
  • Thus far in H2 2022, China has imposed lockdowns in multiple major cities. With the uncertainty over the duration of COVID, no immediate respite is seen in Angelalign’s business.

Leapmotor IPO Valuation Analysis

By Douglas Kim

  • Our base valuation of Leapmotor HKD 34.9 per share, which is 27% lower than the low end of the IPO price range of HKD 48 per share. 
  • Given the steep downside of our target price (6-12 month period) relative to the IPO price range, we are Negative on  the Leapmotor IPO.
  • Leapmotor is selling 130.82 million shares in the IPO at a price range of HKD 48 to HKD 62 per share, scaling back the size of the IPO considerably. 

SKYX Platforms Inc. – Investment Thesis

By Baptista Research

  • This is our first report on SKYX Platforms and we look to provide a detailed account of the various drivers that will be responsible for the company’s growth in the coming years.
  • Another important fact about SKYX Platforms is that the company’s management comprises several former GE and NEC employees which is a big positive.
  • We believe that there is a good chance the company’s offerings may become universally accepted in the years to come.

Central China – Tear Sheet – Lucror Analytics

By Leonard Law, CFA

We view Central China Real Estate (CCRE) as “High Risk” on the LARA scale. The company’s operations are geographically concentrated in Henan, China’s third-most populous province. While this exposes CCRE to policy and political changes within the province, we believe the risks are partly mitigated by the company’s deep market knowledge, brand recognition, as well as longstanding relationships with the local government and construction companies. Our view also considers the deteriorated operating and financing environment across the Chinese property industry, which has adversely impacted CCRE and other private developers.

Our fundamental Credit Bias on CCRE is “Negative”, given the company’s weak sales, very low margins, poor liquidity and lack of access to capital market financing amid the industry turmoil. Moreover, CCRE has material non-debt liabilities. Going forward, the company’s debt repayment prospects may hinge on the development of synergies with its SOE minority investor (Henan Railway) to achieve new business and financing opportunities.

Controversies for CCRE are “Immaterial”, despite reputational risk on account of worker fatalities. This was mainly reported in the media in 2019 and 2020, with such statistics not provided in the company’s ESG reports. The ESG Impact on Credit is “Neutral”. We note positively that CCRE’s corporate governance has improved, supported by increased transparency and its willingness to honour debt obligations.


Jupiter Wellness – Investment Thesis, Key Drivers, Financial & Price Forecasts, DCF Valuation 09/22

By Baptista Research

  • This is our first report on Jupiter Wellness and we look to provide a detailed account of the various drivers that will be responsible for the company’s growth in the coming years.
  • With all of these developments, a stock priced at 63 cents appears to be highly affordable and supports our positive outlook.
  • Overall, we believe that Jupiter has phenomenal growth prospects and is an excellent investment prospect.

Angelalign Technology (6699.HK) 22H1 – Still “Bubble” in Valuation; The Era of High Margin Is Over

By Xinyao (Criss) Wang

  • Due to declining performance, lack of core competitiveness and increasing competition, the market has to re-examine the growth potential and outlook of Angelalign.The era of high margin is fading away.
  • Angelalign’s low-price strategy is easily hit by similar products with lower prices. Once its price loses advantage, it will directly lead to a rapid and substantial decline in overall performance.
  • Due to its worse-than-expected 2022H1 performance and economic downturn, we lowered our 2022 forecast of Angelalign. Angelalign shouldn’t be valued that much higher than Align Technology, expecting more downside ahead. 

Morning Views Asia: CIFI Holdings

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Air China (753 HK): Can It Sustain the Outperformance?

By Osbert Tang, CFA

  • Despite record losses in 2Q22, share price of Air China Ltd (H) (753 HK) has rallied 14% YTD, outperformed the 23.9% decline in HSCEI and its Chinese peers. 
  • Air China’s stub value has returned to pre-pandemic level, but is primarily driven by the A-share. Cathay Pacific (293 HK) recovery is an important catalyst for narrowing H-A share discount.
  • News flow over the next 12 months, mostly related to further relaxation of quarantine requirements, will be positive. The surge in demand should support elevated passenger yield.  

Bruush Oral Care – Investment Thesis, Key Drivers, Financial & Price Forecasts, DCF Valuation 07/22

By Baptista Research

  • This is our first report on Bruush Oral Care and we look to provide a detailed account of the drivers that will propel the stock in the near future.
  • Bruush got listed recently and its stock price has been volatile but has maintained a more or less sideways trajectory in this short period of time.
  • Overall, we believe that Bruush Oral Care has phenomenal growth prospects and is an excellent investment prospect.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Leapmotor, Shandong Fengxiang Co Ltd-H, Onewo Space-Tech, CALB, Tencent Music, Remegen Co Ltd, Godaddy Inc Class A, Jenscare Scientific and more

By | China, Daily Briefs

In today’s briefing:

  • Leapmotor IPO – Peers Recent Down Move Won’t Help
  • Leapmotor IPO: Valuation Insights
  • Leapmotor IPO: Stuck in the Middle
  • Fengxiang’s Judicial Auction Set for 10 October, Potential MGO
  • Onewo Space-Tech IPO Valuation Analysis
  • CALB IPO: What’s It Worth?
  • Tencent Music – Earnings Show Recovery but Do Not Rush to Make an Entry
  • Remegen Co Ltd (9995.HK) 22H1 – Mr. Market’s “Misjudgment” Brings Opportunities to Make Money
  • GoDaddy Inc: Initiation of Coverage – Business Strategy
  • Jenscare (宁波健世科技) Pre-IPO:  Massive Delays After Missing the Boat

Leapmotor IPO – Peers Recent Down Move Won’t Help

By Sumeet Singh

  • Leapmotor (LM) aims to raise around US$1.0bn in its Hong Kong IPO. LM is a smart EV company based in China, founded in 2015.
  • As of end Jun 22, it had delivered a total of 104,829 cars with most of its sales coming from its mini units, T03.
  • In this note, we will run the deal through our ECM framework and talk about valuations.

Leapmotor IPO: Valuation Insights

By Arun George


Leapmotor IPO: Stuck in the Middle

By Shifara Samsudeen, ACMA, CGMA

  • Leapmotor (2007699D HK) is a leading smart EV company in China that designs and builds EVs. The company develops key hardware, software and all electronic components of the vehicles internally.
  • The company has filed for an IPO on the HKEx and plans to raise about US$1bn through the IPO.
  • In this insight, we analyse the company’s financials to understand the key reason behind the absence of gross profit margins compared to other players in the market.

Fengxiang’s Judicial Auction Set for 10 October, Potential MGO

By Arun George

  • On 16 September, the administrator published the details for the auction of Shandong Fengxiang Co Ltd-H (9977 HK) controlling shareholder’s 70.92% stake in Alibaba Judicial Auction. 
  • If the auction is successful and results in any person and a group of persons acting in concert holding 30%+ of the voting rights, it will result in an MGO.
  • The base bid implies an MGO price of HK$1.563 per H Share, a 103.0% premium to the last close. The auction will be held from 10 October to 11 October.

Onewo Space-Tech IPO Valuation Analysis

By Douglas Kim

  • Onewo Space-Tech (ONEWO HK) has provided its IPO price range of HK$47.1 to HK$52.7 a piece in the IPO offering of 116.74 million shares, representing 10% of its outstanding shares.
  • Our base case valuation of Onewo Spacetech is HKD27.7 per share, which represents 41% lower than the low end of the IPO price of HKD47.1 per share. 
  • Our valuation analysis suggests a range of HKD25 per share to HKD33.5 per share. We would AVOID this deal due to the much lower target price relative to IPO price.

CALB IPO: What’s It Worth?

By Arun George


Tencent Music – Earnings Show Recovery but Do Not Rush to Make an Entry

By Shifara Samsudeen, ACMA, CGMA

  • TME’s shares are due to start trading on HKEx tomorrow once it carries out a secondary listing by introduction. The company neither issues new shares nor raise any proceeds.
  • The company’s earnings growth has started decelerating with having to end exclusive music licensing agreements with WMG, UMG and Sony Music a year ago as part of a SAMR probe.
  • TME’s 2Q2022 results show recovery in its earnings, however, we would recommend waiting until regulatory crackdown on tech platforms eases off.

Remegen Co Ltd (9995.HK) 22H1 – Mr. Market’s “Misjudgment” Brings Opportunities to Make Money

By Xinyao (Criss) Wang

  • For RC18, it depends on whether RemeGen can seize this short period of strategic opportunities to further establish its leading position. The situation faced by RC48 is much more complex.
  • From the current situation, it’s very challenging for RemeGen to evolve into biopharma.That is to say, RemeGen’s future positioning is still likely to remain a biotech, which limits valuation expansion.
  • Even based on conservative forecast, there’s still decent upside potential. We’re bullish on RemeGen. Due to unfriendly macro, investors may need to consider the potential downside risks when going long.

GoDaddy Inc: Initiation of Coverage – Business Strategy

By Baptista Research

  • This is our first report on cloud-based solutions provider, GoDaddy.
  • The company is one of the largest players in the domains, hosting and other related cloud-based solutions space across the globe.
  • This quarter, the company launched its beta WooSaas solution, allowing it to reach larger customers.

Jenscare (宁波健世科技) Pre-IPO:  Massive Delays After Missing the Boat

By Ke Yan, CFA, FRM

  • Jenscare, a China based structural heart disease focused medical device company, plans to raise up to USD 30m via a Hong Kong listing.
  • In our previous insight, we discussed that there have been many TAVR companies listed in Hong Kong but we think Jenscare has a differentiated portfolio.
  • In this note, we will look at updates in its latest filing and highlight massive delays in its product candidates. We also provide a quick thought on its valuation.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Onewo Space-Tech, Meituan, Aier Eye Hospital Group, CPMC Holdings, Country Garden Holdings Co and more

By | China, Daily Briefs

In today’s briefing:

  • Onewo Space-Tech IPO – Appears Digestible Even on Conservative Assumptions
  • Meituan (3690 HK): User Base Beating Competitor, Industry Recovering, Upgrade to Hold
  • Aier Eye Hospital (300015.CH) 22H1 – More Downside Ahead; The Long Logic Doesn’t Exist
  • CPMC Holdings (906 HK): Good Time to Re-Visit
  • Morning Views Asia: China Vanke, Country Garden Holdings Co

Onewo Space-Tech IPO – Appears Digestible Even on Conservative Assumptions

By Sumeet Singh

  • Onewo Space-Tech (ONEWO HK) (OST) aims to raise upto US$784m in its Hong Kong IPO. OST is a property management service provider primarily owned by China Vanke (2202 HK)
  • As per Frost & Sullivan, amongst the residential community service providers in China, OST ranked first. It also ranked first in the commercial space integrated services market in China.
  • In this note, we will run the deal through our ECM framework and talk about valuations.

Meituan (3690 HK): User Base Beating Competitor, Industry Recovering, Upgrade to Hold

By Ming Lu

  • In July, Meituan’s user base exceeded Ele.me and Ele.me’s active user base decreased by 24% YoY.
  • In China, Monthly active user bases of local life and food delivery recovered from May to July.
  • We believe Meituan’s stock has only a downside of 6% for year end 2023.

Aier Eye Hospital (300015.CH) 22H1 – More Downside Ahead; The Long Logic Doesn’t Exist

By Xinyao (Criss) Wang

  • The fundamental changes in the population structure will lead to a decline in the growth rate of the total retail sales of consumer goods. The long logic doesn’t exist.
  • Aier has hit a growth ceiling. As the endogenous demand will be stepped downward gradually, the performance of Aier will further decline. The downward elasticity of valuation is greater.
  • It is still difficult for healthcare sector to have its own independent growth logic. The bottom of healthcare sector would appear after the collapse of Aier’s valuation.

CPMC Holdings (906 HK): Good Time to Re-Visit

By Osbert Tang, CFA

  • Underpinned by higher ASP and sequentially lower input costs, CPMC Holdings (906 HK) should achieve better margin in 2H22. Its 17% fall in share price YTD makes it appealing.
  • Average aluminum price was down 14% so far in 2H22, vs. 1H21, good to its costs. Well-controlled selling and administrative costs will help to support profitability recovery.
  • New two-piece can capacity will grow by 54% over the next three years as 5 production lines are expected to be added. Most of them already have demand lined up.

Morning Views Asia: China Vanke, Country Garden Holdings Co

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Shanghai United Imaging Healthcare, Times Neighborhood, Onewo Space-Tech, Tencent, Road King Infrastructure and more

By | China, Daily Briefs

In today’s briefing:

  • Index Rebalance & ETF Flow Recap: STAR50, PCOMP, SET50, AMFI, ALX
  • Takeaways from the Times Neighborhood Investment Debacle
  • Onewo IPO: Valuation Insights
  • China Internet Weekly (19Sep2022): Tencent, NetEase, Meituan, Trip.com
  • Morning Views Asia: China Fortune Land, Fosun International, Road King Infrastructure

Index Rebalance & ETF Flow Recap: STAR50, PCOMP, SET50, AMFI, ALX

By Brian Freitas


Takeaways from the Times Neighborhood Investment Debacle

By Sameer Taneja

  • Times Neighborhood (9928 HK) has been a disastrous call since we first highlighted it. In this insight, we reflect upon the red flags we could have done well to spot. 
  • We cover red flags ranging from the level of precise guidance, pivot in strategy, and the parent’s poor financial health, to the effect on receivables sucking cash from the company. 
  • Everyone makes mistakes (we are human, after all). We would like to share our experience to educate readers to become better investors and sidestep investments in such names.  

Onewo IPO: Valuation Insights

By Arun George


China Internet Weekly (19Sep2022): Tencent, NetEase, Meituan, Trip.com

By Ming Lu

  • Tencent and NetEase received new licenses from the authorities more than a year.
  • Meituan’s car-hailing service joined Tencent WeChat’s traffic platform, Tencent Passenger Traffic.
  • Express parcels and their revenue continued to recover in August.

Morning Views Asia: China Fortune Land, Fosun International, Road King Infrastructure

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Keda Industrial Group, Genuine Biotech, CALB, Leapmotor and more

By | China, Daily Briefs

In today’s briefing:

  • Keda Industrial (600499 CH): Lithium Play Backed by Multi-Pronged Growth Strategies
  • Keda Industrial Group: Concerns About Downturn in Ceramics Machinery Market & Uncompelling Valuation
  • Genuine Biotech (GBL HK): COVID Pill No Longer Attractive Opportunity; Thin Pipeline Mars Conviction
  • ECM Weekly (18th Sep 2022) – CALB, Onewo, Leapmotor, WCP, Biogene, Socionext, Prop Guru, PayMate
  • Weekly Deals Digest (18 Sep) – Leapmotor, Onewo, WCP, Link, Ramsay, Giordano, VNET, FHT, Moya

Keda Industrial (600499 CH): Lithium Play Backed by Multi-Pronged Growth Strategies

By Osbert Tang, CFA

  • Through its 43.58% ownership in lithium carbonate producer Lanke Lithium Industry, Keda Industrial Group (600499 CH) is well placed to benefit from the increase in lithium demand.
  • Lanke’s capacity has recently been upgraded to 30,000 tonnes. Also, Keda is adding capacity to its own integrated anode materials factory in Fujian to capture the ever-rising demand. 
  • Overseas ceramic business will see solid growth from key markets in Africa as Keda raises capacity by 65% by FY23. The stock’s valuations are inexpensive relative to peers. 

Keda Industrial Group: Concerns About Downturn in Ceramics Machinery Market & Uncompelling Valuation

By Douglas Kim

  • We are Negative on Keda Industrial over the next year due to a potential downturn in the ceramics machinery market, uncompelling valuations, and concerns about expansion into lithium battery materials. 
  • Keda Industrial Group is one of the world’s leading suppliers of building ceramic machinery and equipment.
  • Its A-Shares listed on Shanghai Stock Exchange and it completed a private placement of GDRs listing the shares in SIX Swiss Exchange in July 2022. 

Genuine Biotech (GBL HK): COVID Pill No Longer Attractive Opportunity; Thin Pipeline Mars Conviction

By Tina Banerjee

  • Genuine Biotech (GBL HK) has filed for HK listing. Its Azvudine received NMPA approval for the treatment of COVID-19 in July 2022 to become the first China-made oral COVID-19 drug.
  • Azvudine was conditionally approved by the NMPA for the treatment of HIV infection in July 2021. However, the drug is yet to be commercialized.
  • Genuine Biotech plans to use the IPO proceeds for the commercialization of Azvudine. The company’s current cash balance can maintain its financial viability for approximately 20 months.

ECM Weekly (18th Sep 2022) – CALB, Onewo, Leapmotor, WCP, Biogene, Socionext, Prop Guru, PayMate

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • On the IPO front, a few large Hong Kong IPOs are rumoured to be aiming to launch their bookbuild next week.
  • There was only the Atlas Arteria (ALX AU) mega entitlement offer this week, on the placements front.

Weekly Deals Digest (18 Sep) – Leapmotor, Onewo, WCP, Link, Ramsay, Giordano, VNET, FHT, Moya

By Arun George


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Hang Seng H Share Index ETF, Sino-Ocean Group, Agile Property Holdings, Onewo Space-Tech, S.F. Holding and more

By | China, Daily Briefs

In today’s briefing:

  • Shanghai/​​​​​​​​​​​​Shenzhen Southbound Connect: Weekly Moves (15 September 2022)
  • Weekly Wrap – 16 Sep 2022
  • Weekly Wrap – 16 Sep 2022
  • Chinese Property Weekly – 16 September 2022 – Lucror Analytics
  • Chinese Property Weekly – 16 September 2022 – Lucror Analytics
  • Onewo Space-Tech IPO (Part II): Margins to Remain Under Pressure in the Near-Term
  • Shanghai/​​​​​​​​​​​​Shenzhen Northbound Connect: Weekly Moves (15 September 2022)

Shanghai/​​​​​​​​​​​​Shenzhen Southbound Connect: Weekly Moves (15 September 2022)

By David Blennerhassett


Weekly Wrap – 16 Sep 2022

By Charles Macgregor

Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.

In this Insight:

  1. Fosun International
  2. China SCE
  3. CIFI Holdings
  4. Vedanta Resources
  5. China Jinmao Holdings

and more…


Weekly Wrap – 16 Sep 2022

By Charles Macgregor

Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.

In this Insight:

  1. Fosun International
  2. China SCE
  3. CIFI Holdings
  4. Vedanta Resources
  5. China Jinmao Holdings

and more…


Chinese Property Weekly – 16 September 2022 – Lucror Analytics

By Charles Macgregor

The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.


Chinese Property Weekly – 16 September 2022 – Lucror Analytics

By Charles Macgregor

The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.


Onewo Space-Tech IPO (Part II): Margins to Remain Under Pressure in the Near-Term

By Shifara Samsudeen, ACMA, CGMA

  • Onewo Space-Tech (ONEWO HK) is a leading property management service provider in China looking to raise US$2bn through an IPO on the HKEx.
  • This is the Second of a series of reports on Onewo IPO and we will be discussing the company’s Commercial and Urban Space services and AIoT and BPaaS solution segments.
  • We expect Onewo’s margins to remain under pressure in the medium-term as the company focuses on customer acquisition which would likely impact margins in the near-term.

Shanghai/​​​​​​​​​​​​Shenzhen Northbound Connect: Weekly Moves (15 September 2022)

By David Blennerhassett


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars